VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 125 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $150,000 | -99.2% | 31,800 | -98.8% | 0.00% | -99.1% |
| Q4 2020 | $19,391,000 | -33.0% | 2,712,083 | 0.0% | 0.22% | -44.5% |
| Q3 2020 | $28,938,000 | -15.5% | 2,712,083 | 0.0% | 0.40% | -17.4% |
| Q2 2020 | $34,226,000 | +37.3% | 2,712,083 | -0.4% | 0.48% | +0.2% |
| Q1 2020 | $24,926,000 | -33.9% | 2,724,083 | +0.7% | 0.48% | -19.2% |
| Q4 2019 | $37,725,000 | -19.0% | 2,704,283 | -0.0% | 0.60% | -30.9% |
| Q3 2019 | $46,548,000 | -36.2% | 2,704,683 | +0.9% | 0.87% | -30.5% |
| Q2 2019 | $72,957,000 | +27746.2% | 2,680,283 | +9506.7% | 1.25% | +7229.4% |
| Q4 2018 | $262,000 | -68.1% | 27,900 | -35.7% | 0.02% | -67.3% |
| Q3 2018 | $822,000 | +148.3% | 43,422 | +156.6% | 0.05% | +85.7% |
| Q2 2018 | $331,000 | – | 16,922 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |